Renyan Gong

1.3k total citations · 1 hit paper
9 papers, 961 citations indexed

About

Renyan Gong is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Renyan Gong has authored 9 papers receiving a total of 961 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 3 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Renyan Gong's work include Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Circular RNAs in diseases (2 papers). Renyan Gong is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Circular RNAs in diseases (2 papers). Renyan Gong collaborates with scholars based in China and Hong Kong. Renyan Gong's co-authors include Yizhou Wang, Zhenlin Yan, Yong Xia, Lehua Shi, Kui Wang, Dong Wu, Feng Shen, Xuying Wan, Mengchao Wu and Guanghua Liu and has published in prestigious journals such as Journal of Clinical Oncology, Biochemical and Biophysical Research Communications and The Oncologist.

In The Last Decade

Renyan Gong

9 papers receiving 958 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostic Nomogram for Intrahepatic Cholangiocarcinoma After Partial Hepatectomy

2013 839 citations Yizhou Wang, Jun Li et al. Journal of Clinical Oncology profile →

Peers

Renyan Gong

SURGE

PRM

ONCOL

CR

HEPAT

Yu-Hong Li China

Alexander Rehders Germany

Ryu Kanzaki Japan

Fuyo Yoshimi Japan

Kathrin Katenkamp Germany

Emmanuelle Samalin France

Akihito Torii Japan

R. Semrau Germany

Naoko Hayashi Japan

Gregory Sergeant Belgium

Yu-Hong Li China

Renyan Gong

285 ×0.5

SURGE

392 ×0.8

PRM

606 ×1.4

ONCOL

205 ×1.1

CR

68 ×0.5

HEPAT

Citations per year, relative to Renyan Gong Renyan Gong (= 1×) peers Yu-Hong Li

Countries citing papers authored by Renyan Gong

Since Specialization

Citations

This map shows the geographic impact of Renyan Gong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renyan Gong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renyan Gong more than expected).

Fields of papers citing papers by Renyan Gong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renyan Gong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renyan Gong. The network helps show where Renyan Gong may publish in the future.

Co-authorship network of co-authors of Renyan Gong

This figure shows the co-authorship network connecting the top 25 collaborators of Renyan Gong. A scholar is included among the top collaborators of Renyan Gong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renyan Gong. Renyan Gong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Wang, Yizhou, et al.. (2020). SNHG7 Facilitates Hepatocellular Carcinoma Occurrence by Sequestering miR-9-5p to Upregulate CNNM1 Expression. Cancer Biotherapy and Radiopharmaceuticals. 35(10). 731–740. 13 indexed citations

2.

Wang, Yu, et al.. (2020). Development and validation of a prognostic and immunotherapeutically relevant model in hepatocellular carcinoma. Annals of Translational Medicine. 8(18). 1177–1177. 8 indexed citations

3.

Liu, Donghong, et al.. (2020). Mechanically Induced Vasospasm‐Evaluation of Spasmolytic Efficacy of 10 Pharmaceutical Agents Using Laser Speckle Contrast Imaging. Lasers in Surgery and Medicine. 53(5). 684–694. 2 indexed citations

4.

Huo, Lei, Wenxin Wei, Zhenlin Yan, et al.. (2019). Short-term and long-term outcomes of liver resection for HCC patients with portal vein tumor thrombus. Cell & Bioscience. 9(1). 23–23. 21 indexed citations

5.

Wang, Yizhou, Xifeng Li, Jianbo Lin, et al.. (2018). MiR-876-5p acts as an inhibitor in hepatocellular carcinoma progression by targeting DNMT3A. Pathology - Research and Practice. 214(7). 1024–1030. 30 indexed citations

6.

Wang, Yizhou, Renyan Gong, Zhenlin Yan, et al.. (2017). Lovastatin induces apoptosis of HepG-2 cells by activating ROS-dependent mitochondrial and ER stress pathways.. PubMed. 10(12). 11480–11488. 6 indexed citations

7.

Wang, Yizhou, Jun Li, Yong Xia, et al.. (2013). Prognostic Nomogram for Intrahepatic Cholangiocarcinoma After Partial Hepatectomy. Journal of Clinical Oncology. 31(9). 1188–1195. 839 indexed citations breakdown →

8.

Li, Xifeng, Renyan Gong, Meng Wang, et al.. (2012). Sorafenib down-regulates c-IAP expression post-transcriptionally in hepatic carcinoma cells to suppress apoptosis. Biochemical and Biophysical Research Communications. 418(3). 531–536. 9 indexed citations

9.

Yan, Zhenlin, Renyan Gong, Yizhou Wang, et al.. (2012). Independent Factors and Predictive Score for Extrahepatic Metastasis of Hepatocellular Carcinoma Following Curative Hepatectomy. The Oncologist. 17(7). 963–969. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact